What's in Sunshine Lake Pharma Co., Ltd.'s pipeline?

Sunshine Lake Pharma Co., Ltd. has 50 drugs in our index: 1 marketed, 0 filed, 7 in Phase 3, 6 in Phase 2, 36 in Phase 1.

Which companies overlap with Sunshine Lake Pharma Co., Ltd.'s portfolio?

Top competitors by shared drug class: Alliance for Clinical Trials in Oncology, Amgen, Asan Medical Center, AstraZeneca, Beijing Friendship Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sunshine-lake-pharma-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Sunshine Lake Pharma Co., Ltd. — Portfolio Competitive Intelligence Brief

Sunshine Lake Pharma Co., Ltd. pipeline: 1 marketed, 0 filed, 7 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 7 Phase 3 6 Phase 2 36 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
entecavir tablets	entecavir tablets	marketed
HEC585	HEC585	phase 3
Ara-C±IDA	Ara-C±IDA	phase 3	Combination chemotherapy (nucleoside analog + anthracycline)	DNA polymerase (Ara-C); Topoisomerase II (IDA)	Oncology
LoDAC	LoDAC	phase 3	Nucleoside analog / Antimetabolite	DNA synthesis (cytidine deaminase inhibition pathway)	Oncology
FLAG-IDA	FLAG-IDA	phase 3	Combination chemotherapy regimen	DNA synthesis machinery; Topoisomerase II	Oncology
Clifutinib	Clifutinib	phase 3			Other
Lerotinib	Lerotinib	phase 3			Other
Irinotecan/Tegafur	Irinotecan/Tegafur	phase 3	Topoisomerase I inhibitor + Fluoropyrimidine antimetabolite combination	Topoisomerase I; Thymidylate synthase	Oncology

Therapeutic area mix

Oncology · 4
Other · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Alliance for Clinical Trials in Oncology · 1 shared drug class
Amgen · 1 shared drug class
Asan Medical Center · 1 shared drug class
AstraZeneca · 1 shared drug class
Beijing Friendship Hospital · 1 shared drug class
Centre Hospitalier Universitaire Dijon · 1 shared drug class
Centre Hospitalier Universitaire de Besancon · 1 shared drug class
Affiliated Cancer Hospital & Institute of Guangzhou Medical University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sunshine Lake Pharma Co., Ltd.:

Cite this brief

Drug Landscape (2026). Sunshine Lake Pharma Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sunshine-lake-pharma-co-ltd. Accessed 2026-05-16.